Grupo de Investigación en Cáncer de Mama
NEONCOBREAST
![Foto de Grupo de Investigación en Cáncer de Mama](/img/uploaded/46084eb269a9135ee7dc8a58bb36982a.jpg)
![Foto de Instituto de Salud Carlos III](/img/noimage_org.png)
Instituto de Salud Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (5)
2022
-
A Fibrosis Biomarker Early Predicts Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy
Cancers, Vol. 14, Núm. 12
-
Conversion to Open Surgery in Laparoscopic Colorectal Cancer Resection: Predictive Factors and its Impact on Long-Term Outcomes. A Case Series Study
Surgical Laparoscopy, Endoscopy and Percutaneous Techniques, Vol. 32, Núm. 1, pp. 28-34
-
Neutrophil Extracellular Traps, Local IL-8 Expression, and Cytotoxic T-Lymphocyte Response in the Lungs of Patients With Fatal COVID-19
Chest, Vol. 162, Núm. 5, pp. 1006-1016
2020
-
Incidental lesions of the pancreas. A clinicopathological study of 100 cases surgically treated
Revista Española de Enfermedades Digestivas, Vol. 112, Núm. 2, pp. 85-89
2018
-
A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation
EMBO Molecular Medicine, Vol. 10, Núm. 12